Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDerwent London Regulatory News (DLN)

Share Price Information for Derwent London (DLN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,322.00
Bid: 2,328.00
Ask: 2,334.00
Change: 10.00 (0.43%)
Spread: 6.00 (0.258%)
Open: 2,326.00
High: 2,340.00
Low: 2,314.00
Prev. Close: 2,312.00
DLN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

West End Sale Announcement

20 Jul 2009 07:00

RNS Number : 9002V
Derwent London PLC
20 July 2009
 



3PRESS RELEASE

20 JULY 2009

Derwent London plc ("Derwent London" / "Company")

DERWENT LONDON ANNOUNCES WEST END SALE 

13-17 FITZROY STREETLONDON W1

Derwent London has exchanged contracts on the sale of its freehold interest at 13-17 Fitzroy Street, London W1 to a member of the Arup group of companies ("Arup") for £60 million, which reflects a net initial yield of 7%.

The sale price represents a decrease of 10% from the 31 December 2008 valuation, which compares to the IPD UK Monthly Property Index for West End & Midtown offices which showed a decline of 14.8% for the first six months of 2009.

The property is fully let to Aruon a lease expiring 2023 at a rent of £4.46 million per annum, subject to five-yearly upward only rent reviews.

Prominently located on the corner of Fitzroy and Howland Street, the eight storey office building totals 90,420 sq ft (8,400 sq m). The property underwent a comprehensive redevelopment which completed in 2003 as the first of a three phase scheme to provide Arup's new global headquarters. Following the sale of Phase I Derwent London will retain the ownership of Phases II and III, with Arup occupying the remaining 147,700 sq ft (13,720 sq m) in its entirety.

John Burns, Chief Executive of Derwent London said:

"We are pleased to have agreed this significant sale which forms part of our programme to recycle capital. Arup is an important tenant on our Fitzrovia Estate with whom we have a long standing relationship. We are committed to the strategic regeneration of the Fitzrovia area, where our ownership extends to over one million sq ft and where we look forward to continuing to work closely with Arup."

-ends-

For further information please contact:

Derwent London

John Burns, Chief Executive, 

Tel - 020 7659 3000

Brunswick Group

Andrew Fenwick / James Rossiter

Tel - 020 7404 5959

Notes to editors:

Derwent London plc

Derwent London plc is the largest central London focussed REIT with an investment portfolio of £2.1 billion as at 31 December 2008. The group is one of London's most innovative office regenerators and investors, well known for its established design-led philosophy and creative approach to development. In April, Derwent London was awarded the Property Week Property Company of the Year 2009.

Derwent London's core strategy is to acquire and own a portfolio of central London property that has reversionary rents and significant opportunities to enhance and extract value through refurbishment and redevelopment. The group owns and manages an investment portfolio, of which 94% is located in central London, with a specific focus on the West End and the areas bordering the City of London.

Landmark schemes by Derwent London include: Qube W1, Horseferry House SW1, Johnson Building EC1, Davidson Building WC2 and Tea Building E1.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISILFESDEIDLIA
Date   Source Headline
12th Jun 202411:00 amRNSHolding(s) in Company
10th Jun 20244:00 pmRNSDirector/PDMR Shareholding
31st May 20244:45 pmRNSTotal Voting Rights
31st May 202410:00 amRNSDirectorate Change
10th May 20241:00 pmRNSResults of 2024 Annual General Meeting
9th May 20247:00 amRNSFirst Quarter Business Update
7th May 20241:00 pmRNSAnnual Bondholders Meeting of LMS Limited
7th May 202410:00 amRNSAdditional Listing
1st May 202411:00 amRNSTotal Voting Rights
25th Apr 202410:00 amRNSSale of Turnmill EC1
9th Apr 20249:30 amRNSNotice of 2024 AGM and 2023 Report & Accounts
28th Mar 20244:45 pmRNSTotal Voting Rights
20th Mar 20245:13 pmRNSBlock listing Interim Review
12th Mar 202410:00 amRNSAdditional Listing
11th Mar 20244:45 pmRNSDirector/PDMR Shareholding
1st Mar 20243:00 pmRNSHolding(s) in Company
29th Feb 20244:45 pmRNSTotal Voting Rights
28th Feb 20247:00 amRNSRESULTS FOR THE YEAR ENDED 31 DECEMBER 2023
31st Jan 20244:45 pmRNSTotal Voting Rights
18th Jan 202411:00 amRNSNotice of Results
9th Jan 202410:10 amRNSHolding(s) in Company
29th Dec 20231:00 pmRNSTotal Voting Rights
1st Dec 20239:45 amRNSHolding(s) in Company
30th Nov 20234:45 pmRNSTotal Voting Rights
17th Nov 20235:35 pmRNSHolding(s) in Company
2nd Nov 20237:00 amRNSDerwent London plc Third Quarter Business Update
31st Oct 20234:45 pmRNSTotal Voting Rights
6th Oct 20239:30 amRNSHolding(s) in Company
5th Oct 20239:45 amRNSHolding(s) in Company
4th Oct 20239:47 amRNSHolding(s) in Company
21st Sep 20233:00 pmRNSDirector/PDMR Shareholding
20th Sep 20234:45 pmRNSBlock listing Interim Review
19th Sep 202310:00 amRNSAdditional Listing
5th Sep 20239:30 amRNSHolding(s) in Company
31st Aug 20234:45 pmRNSTotal Voting Rights
10th Aug 20237:01 amRNSH2 2023 LETTING UPDATE
10th Aug 20237:00 amRNSDerwent London plc - UNAUDITED RESULTS
8th Aug 20233:00 pmRNSHolding(s) in Company
31st Jul 20234:45 pmRNSTotal Voting Rights
30th Jun 20234:45 pmRNSTotal Voting Rights
31st May 20234:45 pmRNSTotal Voting Rights
17th May 20235:30 pmRNSHolding(s) in Company
12th May 20233:00 pmRNSResult of AGM
10th May 20232:30 pmRNSBondholders Meeting
4th May 20237:00 amRNSQ1 2023 Business Update
28th Apr 20234:45 pmRNSTotal Voting Rights
13th Apr 20239:00 amRNS2022 Report & Accounts and Notice of AGM
4th Apr 20233:30 pmRNSDirector/PDMR Shareholding
31st Mar 20234:45 pmRNSTotal Voting Rights
21st Mar 20239:30 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.